Compared to Estimates, Ultragenyx (RARE) Q2 Earnings: A Look at Key Metrics
RAREUltragenyx Pharmaceutical(RARE) ZACKS·2024-08-02 08:00

Ultragenyx (RARE) reported 147.03millioninrevenueforthequarterendedJune2024,representingayear−over−yearincreaseof35.8147.03 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 35.8%. EPS of -1.52 for the same period compares to -2.25ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof2.25 a year ago.The reported revenue compares to the Zacks Consensus Estimate of 123.42 million, representing a surprise of +19.13%. The company delivered an EPS surprise of +7.32%, with the consensus EPS estimate being -$1.64.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wal ...